550 is the total number of securities ACUTA CAPITAL PARTNERS, LLC has owned. The longest ACUTA CAPITAL PARTNERS, LLC has owned a single stock is 24 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 24 | 24 | 0.60% | 5.96% | 21.16% | Q2 2017 | Q1 2023 | 24 |
| IRIX | IRIDEX CORP | 20 | 20 | 1.21% | 3.46% | 8.13% | Q4 2014 | Q3 2019 | 20 |
| ARWR | ARROWHEAD PHARMACEUTIC... | 16 | 1 | 0.66% | 2.74% | 7.88% | Q1 2018 | Q2 2023 | 20 |
| IMMU | IMMUNOMEDICS INC | 16 | 1 | 0.77% | 7.93% | 20.59% | Q3 2015 | Q3 2020 | 19 |
| VCYT | VERACYTE INC | 18 | 1 | 0.19% | 5.21% | 10.11% | Q4 2014 | Q3 2019 | 19 |
| ASND | ASCENDIS PHARMA A S | 15 | 3 | 0.78% | 3.88% | 7.18% | Q1 2015 | Q2 2020 | 18 |
| XENE | XENON PHARMACEUTICALS INC | 18 | 18 | 0.34% | 2.66% | 4.62% | Q2 2018 | Q3 2022 | 18 |
| CASM | CAS MED SYS PAR $0.004 | 18 | 18 | 0.58% | 2.41% | 6.42% | Q4 2014 | Q1 2019 | 18 |
| APLS | APELLIS PHARMACEUTICAL... | 16 | 1 | 0.66% | 6.88% | 18.37% | Q2 2018 | Q3 2023 | 17 |
| KURA | KURA ONCOLOGY INC. COM... | 17 | 17 | 0.82% | 3.72% | 8.10% | Q3 2019 | Q3 2023 | 17 |
| CEMI | CHEMBIO DIAGNOSTICS INC | 14 | 3 | 0.05% | 1.83% | 7.60% | Q4 2014 | Q3 2019 | 17 |
| ALIM | ALIMERA SCIENCES INC | 16 | 16 | 0.09% | 1.10% | 4.45% | Q4 2014 | Q3 2018 | 16 |
| XBI | SPDR SER TR | 8 | 1 | 1.70% | 6.34% | 12.00% | Q3 2015 | Q3 2020 | 15 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 14 | 1 | 0.02% | 5.64% | 12.40% | Q4 2014 | Q3 2019 | 15 |
| ISEE | IVERIC BIO INC | 15 | 15 | 0.23% | 3.20% | 6.50% | Q4 2019 | Q2 2023 | 15 |
| ACRS | ACLARIS THERAPEUTICS INC | 11 | 1 | 0.43% | 1.39% | 3.76% | Q4 2016 | Q3 2023 | 15 |
| FOLD | AMICUS THERAPEUTICS INC | 9 | 1 | 0.12% | 5.90% | 18.00% | Q4 2014 | Q3 2022 | 14 |
| CLDX | CELLDEX THERAPEUTICS I... | 14 | 14 | 2.26% | 5.31% | 13.20% | Q2 2020 | Q3 2023 | 14 |
| SNDX | SYNDAX PHARMACEUTICALS... | 14 | 14 | 0.96% | 2.58% | 5.13% | Q2 2020 | Q3 2023 | 14 |
| MRTX | MIRATI THERAPEUTICS INC | 4 | 1 | 0.31% | 1.39% | 3.53% | Q4 2015 | Q3 2022 | 14 |
| IWM | ISHARES TR | 9 | 4 | 1.86% | 6.93% | 18.59% | Q4 2014 | Q1 2018 | 13 |
| ARGX | ARGENX SE | 10 | 3 | 0.88% | 3.17% | 6.68% | Q2 2017 | Q2 2023 | 13 |
| BCRX | BIOCRYST PHARMACEUTICALS | 6 | 1 | 0.10% | 1.01% | 2.62% | Q3 2015 | Q3 2020 | 13 |
| KDMN | KADMON HLDGS INC | 12 | 12 | 1.89% | 6.42% | 11.96% | Q3 2017 | Q2 2020 | 12 |
| BLU | BELLUS HEALTH INC NEW | 7 | 4 | 1.52% | 3.51% | 6.54% | Q3 2019 | Q1 2023 | 11 |
| EYPT | EYEPOINT PHARMACEUTICA... | 11 | 11 | 0.65% | 1.33% | 2.25% | Q1 2021 | Q3 2023 | 11 |
| NEURODERM ORD SHS | 10 | 10 | 0.61% | 3.75% | 6.53% | Q1 2015 | Q2 2017 | 10 | |
| CBAY | CYMABAY THERAPEUTICS I... | 5 | 1 | 0.39% | 2.36% | 5.64% | Q1 2019 | Q3 2023 | 10 |
| CBIO | CATALYST BIOSCIENCES INC | 7 | 3 | 0.53% | 2.07% | 4.87% | Q4 2017 | Q3 2021 | 10 |
| VRAY | VIEWRAY INC | 10 | 10 | 1.04% | 1.88% | 3.35% | Q1 2017 | Q2 2019 | 10 |
| VSTM | VERASTEM INC | 10 | 10 | 0.13% | 1.80% | 4.60% | Q1 2020 | Q2 2022 | 10 |
| FULC | FULCRUM THERAPEUTICS INC | 10 | 10 | 0.55% | 1.72% | 3.21% | Q3 2020 | Q4 2022 | 10 |
| ONS | ONCOBIOLOGICS INC | 10 | 10 | 0.00% | 0.09% | 0.40% | Q2 2016 | Q3 2018 | 10 |
| AADI BIOSCIENCES INC | 9 | 9 | 6.00% | 11.31% | 15.85% | Q3 2021 | Q3 2023 | 9 | |
| LBIO | LION BIOTECHNOLOGIES INC | 9 | 9 | 4.38% | 7.65% | 12.58% | Q1 2015 | Q1 2017 | 9 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 9 | 9 | 0.79% | 3.03% | 7.13% | Q3 2021 | Q3 2023 | 9 |
| EDGE | EDGE THERAPEUTICS INC | 9 | 9 | 0.95% | 2.71% | 4.84% | Q4 2015 | Q4 2017 | 9 |
| AUPH | AURINIA PHARMACEUTICAL... | 4 | 2 | 0.62% | 2.32% | 5.42% | Q1 2015 | Q1 2020 | 9 |
| GHRS | GH RESEARCH PLC | 9 | 9 | 1.22% | 2.17% | 4.12% | Q2 2021 | Q2 2023 | 9 |
| OXFD | OXFORD IMMUNOTEC GLOBA... | 9 | 9 | 1.05% | 1.81% | 2.64% | Q1 2015 | Q1 2017 | 9 |
| NUVBWS | NUVATION BIO INC | 6 | 3 | 0.01% | 0.04% | 0.09% | Q1 2021 | Q3 2023 | 9 |
| BLSA | BCLS ACQUISITION CORP-... | 8 | 8 | 2.55% | 3.49% | 4.65% | Q4 2020 | Q3 2022 | 8 |
| AVDL | AVADEL PHARMACEUTICALS... | 7 | 1 | 0.96% | 3.31% | 10.15% | Q4 2019 | Q1 2022 | 8 |
| RLMD | RELMADA THERAPEUTICS INC | 4 | 4 | 1.05% | 3.26% | 5.83% | Q1 2020 | Q3 2022 | 8 |
| MRSN | MERSANA THERAPEUTICS INC | 5 | 1 | 0.08% | 2.60% | 5.02% | Q1 2020 | Q3 2023 | 8 |
| JYAC | JIYA ACQUISITION CORP ... | 8 | 8 | 1.58% | 2.27% | 3.09% | Q4 2020 | Q3 2022 | 8 |
| INSM | INSMED INC | 4 | 1 | 0.14% | 2.15% | 5.11% | Q4 2014 | Q1 2021 | 8 |
| SRPT | SAREPTA THERAPEUTICS INC | 3 | 1 | 0.59% | 2.04% | 5.38% | Q3 2015 | Q3 2023 | 8 |
| ACAD | ACADIA PHARMACEUTICALS... | 7 | 1 | 0.51% | 2.00% | 4.67% | Q2 2016 | Q2 2022 | 8 |
| HSAQ | HEALTH SCIENCES ACQUIS... | 8 | 8 | 1.17% | 1.59% | 2.18% | Q3 2020 | Q2 2022 | 8 |
| ESSA PHARMA INC | 8 | 8 | 0.07% | 0.64% | 1.04% | Q3 2015 | Q2 2017 | 8 | |
| VTGN | VISTAGEN THERAPEUTICS INC | 7 | 7 | 3.96% | 8.78% | 14.76% | Q4 2020 | Q2 2022 | 7 |
| AXSM | AXSOME THERAPEUTICS INC | 7 | 7 | 0.13% | 5.53% | 15.55% | Q2 2019 | Q4 2020 | 7 |
| VENTYX BIOSCIENCES INC | 7 | 7 | 0.45% | 3.12% | 5.15% | Q1 2022 | Q3 2023 | 7 | |
| RRM | RRSAT GLOBAL COMM NTWR... | 7 | 7 | 1.91% | 2.73% | 4.44% | Q4 2014 | Q2 2016 | 7 |
| BEAT | BIOTELEMETRY INC | 5 | 1 | 0.20% | 2.17% | 3.85% | Q4 2014 | Q1 2018 | 7 |
| CEMP | CEMPRA INC | 7 | 7 | 0.24% | 2.12% | 4.92% | Q1 2015 | Q3 2016 | 7 |
| NBRV | NABRIVA THERAPEUTICS AG | 7 | 7 | 1.54% | 1.94% | 2.73% | Q3 2015 | Q1 2017 | 7 |
| ATHA | ATHIRA PHARMA INC | 7 | 7 | 0.88% | 1.92% | 3.66% | Q3 2020 | Q1 2022 | 7 |
| MRUS | MERUS NV | 5 | 1 | 0.51% | 1.78% | 3.15% | Q3 2019 | Q3 2022 | 7 |
| SELB | SELECTA BIOSCIENCES INC | 4 | 3 | 1.32% | 1.74% | 2.76% | Q4 2019 | Q3 2021 | 7 |
| CLSD | CLEARSIDE BIOMEDICAL INC | 5 | 2 | 0.26% | 1.27% | 2.79% | Q4 2016 | Q3 2021 | 7 |
| ZFGN | ZAFGEN INC | 4 | 1 | 0.28% | 1.25% | 3.34% | Q4 2014 | Q1 2020 | 7 |
| RETA | REATA PHARMACEUTICALS INC | 4 | 3 | 0.50% | 1.22% | 2.61% | Q3 2019 | Q3 2021 | 7 |
| PMVP | PMV PHARMACEUTICALS INC | 5 | 2 | 0.16% | 0.73% | 1.32% | Q4 2020 | Q1 2023 | 7 |
| ARVN | ARVINAS INC | 6 | 6 | 1.19% | 4.27% | 8.81% | Q1 2019 | Q2 2020 | 6 |
| RCKT | ROCKET PHARMACEUTICALS... | 4 | 1 | 0.30% | 2.89% | 4.97% | Q1 2018 | Q3 2023 | 6 |
| MIST | MILESTONE PHARMACEUTIC... | 3 | 3 | 1.14% | 2.57% | 4.97% | Q2 2019 | Q3 2022 | 6 |
| SAGE | SAGE THERAPEUTICS INC | 4 | 1 | 0.34% | 2.49% | 6.02% | Q1 2015 | Q2 2021 | 6 |
| ALT | ALTIMMUNE INC | 4 | 1 | 0.60% | 1.54% | 2.47% | Q2 2020 | Q3 2022 | 6 |
| KALV | KALVISTA PHARMACEUTICA... | 6 | 6 | 0.21% | 1.46% | 2.80% | Q3 2018 | Q4 2019 | 6 |
| RARX | RA PHARMACEUTICALS INC | 4 | 1 | 0.19% | 1.12% | 2.13% | Q4 2016 | Q3 2019 | 6 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 3 | 3 | 0.04% | 1.09% | 1.95% | Q4 2016 | Q3 2018 | 6 |
| RNA | AVIDITY BIOSCIENCES INC | 6 | 6 | 0.52% | 1.04% | 1.80% | Q2 2020 | Q3 2021 | 6 |
| BHVN | BIOHAVEN PHARMACTL HLD... | 5 | 1 | 0.38% | 0.96% | 1.52% | Q2 2018 | Q4 2020 | 6 |
| VIVE | VIVEVE MED INC | 6 | 6 | 0.13% | 0.81% | 1.71% | Q1 2017 | Q2 2018 | 6 |
| RZLT | REZOLUTE INC | 6 | 6 | 0.27% | 0.58% | 1.16% | Q2 2022 | Q3 2023 | 6 |
| RMTI | ROCKWELL MED INC | 4 | 2 | 0.02% | 0.28% | 0.48% | Q4 2016 | Q2 2018 | 6 |
| ONSIZ | ONCOBIOLOGICS INC | 6 | 6 | 0.00% | 0.02% | 0.04% | Q2 2016 | Q3 2017 | 6 |
| ONSIW | ONCOBIOLOGICS INC | 6 | 6 | 0.00% | 0.01% | 0.02% | Q2 2016 | Q3 2017 | 6 |
| ADVM | ADVERUM BIOTECHNOLOGIE... | 3 | 2 | 2.29% | 5.94% | 10.54% | Q1 2019 | Q2 2020 | 5 |
| TERN | TERNS PHARMACEUTICALS INC | 5 | 5 | 0.89% | 5.00% | 9.59% | Q3 2022 | Q3 2023 | 5 |
| BHVN | BIOHAVEN PHARMACTL HLD... | 5 | 5 | 1.13% | 3.44% | 5.29% | Q2 2018 | Q2 2019 | 5 |
| PCVX | VAXCYTE INC | 5 | 5 | 0.88% | 3.35% | 4.26% | Q3 2022 | Q3 2023 | 5 |
| UTHR | UNITED THERAPEUTICS DEL | 4 | 1 | 0.20% | 2.78% | 5.65% | Q3 2021 | Q1 2023 | 5 |
| IMVT | IMMUNOVANT INC | 3 | 2 | 1.82% | 2.71% | 3.56% | Q2 2020 | Q3 2023 | 5 |
| INTEC PHARMA LTD JERUS... | 5 | 5 | 0.64% | 2.56% | 4.37% | Q2 2017 | Q2 2018 | 5 | |
| CYNA | CYNAPSUS THERAPEUTICS INC | 5 | 5 | 0.93% | 2.45% | 3.93% | Q2 2015 | Q2 2016 | 5 |
| SEEL | SEELOS THERAPEUTICS INC | 5 | 5 | 0.12% | 2.07% | 3.09% | Q1 2021 | Q1 2022 | 5 |
| DRNA | DICERNA PHARMACEUTICAL... | 3 | 2 | 1.25% | 2.02% | 2.29% | Q1 2019 | Q2 2020 | 5 |
| BBW | BUILD A BEAR WORKSHOP | 5 | 5 | 0.98% | 1.66% | 2.48% | Q4 2014 | Q4 2015 | 5 |
| INNL | INNOCOLL AG SPONSORED ADR | 5 | 5 | 0.66% | 1.43% | 2.15% | Q4 2014 | Q4 2015 | 5 |
| ZGNX | ZOGENIX INC | 4 | 1 | 0.87% | 1.41% | 2.27% | Q1 2017 | Q2 2018 | 5 |
| WBMD | WEBMD HEALTH CORP | 3 | 1 | 0.54% | 1.27% | 1.84% | Q3 2015 | Q2 2017 | 5 |
| KRTX | KARUNA THERAPEUTICS INC | 5 | 5 | 0.14% | 1.19% | 2.51% | Q4 2019 | Q4 2020 | 5 |
| AGEN | AGENUS INC | 2 | 1 | 0.28% | 1.16% | 2.37% | Q4 2014 | Q2 2020 | 5 |
| DBVT | DBV TECHNOLOGIES S A | 5 | 5 | 0.77% | 1.15% | 1.46% | Q3 2016 | Q3 2017 | 5 |
| PYXIS ONCOLOGY INC SER... | 5 | 5 | 0.38% | 1.10% | 3.12% | Q4 2021 | Q4 2022 | 5 | |
| TSRO | TESARO INC | 2 | 1 | 0.40% | 0.93% | 1.28% | Q2 2016 | Q2 2018 | 5 |
| HZNP | HORIZON THERAPEUTICS PLC | 5 | 5 | 0.11% | 0.85% | 1.63% | Q1 2022 | Q1 2023 | 5 |
| CBMX | COMBIMATRIX CORPORATION | 5 | 5 | 0.25% | 0.77% | 1.41% | Q4 2014 | Q4 2015 | 5 |
| GOSS | GOSSAMER BIO INC | 2 | 1 | 0.15% | 0.75% | 1.47% | Q1 2019 | Q3 2022 | 5 |
| CUTR | CUTERA INC | 3 | 2 | 0.58% | 0.73% | 0.88% | Q2 2015 | Q2 2018 | 5 |
| CRDC | CARDICA INC | 5 | 5 | 0.09% | 0.52% | 0.96% | Q4 2014 | Q4 2015 | 5 |
| KIN | KINDRED BIOSCIENCES INC | 5 | 5 | 0.08% | 0.35% | 0.86% | Q4 2014 | Q4 2015 | 5 |
| AMAG | AMAG PHARMACEUTICALS INC | 5 | 5 | 0.16% | 0.22% | 0.33% | Q3 2017 | Q3 2018 | 5 |
| MNKD | MANNKIND CORP | 5 | 5 | 0.01% | 0.06% | 0.14% | Q2 2017 | Q2 2018 | 5 |
| EVDY | EVERYDAY HEALTH INC | 4 | 4 | 1.03% | 2.92% | 4.48% | Q4 2015 | Q3 2016 | 4 |
| PRAX | PRAXIS PRECISION MEDIC... | 2 | 2 | 1.13% | 2.85% | 5.14% | Q4 2020 | Q3 2023 | 4 |
| PTX | PERNIX THERAPEUTICS HLDGS | 2 | 2 | 0.61% | 2.41% | 3.83% | Q4 2014 | Q4 2015 | 4 |
| ETNB | 89BIO INC | 3 | 1 | 0.34% | 2.37% | 3.36% | Q3 2020 | Q3 2023 | 4 |
| IMMUNOMEDICS INC | 4 | 4 | 1.18% | 2.30% | 3.87% | Q1 2016 | Q4 2016 | 4 | |
| AKBA | AKEBIA THERAPEUTICS INC | 4 | 4 | 1.95% | 2.30% | 2.70% | Q1 2016 | Q4 2016 | 4 |
| TRILLIUM THERAPEUTICS INC | 3 | 1 | 0.12% | 2.30% | 3.29% | Q4 2014 | Q1 2021 | 4 | |
| DERM | DERMIRA INC | 3 | 1 | 1.00% | 2.21% | 4.10% | Q2 2016 | Q1 2019 | 4 |
| SRPT | SAREPTA THERAPEUTICS INC | 2 | 1 | 0.73% | 2.03% | 5.08% | Q4 2015 | Q3 2023 | 4 |
| MRVL | MARVELL TECHNOLOGY GRO... | 4 | 4 | 1.10% | 1.87% | 2.58% | Q2 2016 | Q1 2017 | 4 |
| AMRN | AMARIN CORP PLC | 3 | 1 | 0.41% | 1.73% | 4.54% | Q3 2018 | Q3 2019 | 4 |
| ALDX | ALDEYRA THERAPEUTICS INC | 3 | 1 | 0.36% | 1.40% | 3.31% | Q2 2020 | Q4 2021 | 4 |
| ACER | ACER THERAPEUTICS INC | 4 | 4 | 0.42% | 1.38% | 2.19% | Q2 2018 | Q1 2019 | 4 |
| EVH | EVOLENT HEALTH INC | 4 | 4 | 0.79% | 1.30% | 1.99% | Q1 2017 | Q4 2017 | 4 |
| APLT | APPLIED THERAPEUTICS INC | 4 | 4 | 0.66% | 1.29% | 1.90% | Q3 2019 | Q2 2020 | 4 |
| ENTA | ENANTA PHARMACEUTICALS... | 2 | 1 | 0.08% | 1.28% | 2.77% | Q4 2014 | Q2 2022 | 4 |
| CMRX | CHIMERIX INC | 3 | 1 | 0.43% | 1.24% | 2.46% | Q2 2019 | Q3 2021 | 4 |
| CRME | CARDIOME PHARMA CORP | 2 | 2 | 0.32% | 1.13% | 1.90% | Q4 2014 | Q4 2015 | 4 |
| NABRIVA THERAPEUTICS PLC | 4 | 4 | 0.46% | 1.12% | 2.77% | Q2 2017 | Q1 2018 | 4 | |
| FLKS | FLEX PHARMA INC | 4 | 4 | 0.53% | 0.89% | 1.49% | Q1 2015 | Q4 2015 | 4 |
| ACAD | ACADIA PHARMACEUTICALS... | 2 | 1 | 0.46% | 0.78% | 1.71% | Q3 2016 | Q4 2017 | 4 |
| QTNT | QUOTIENT LTD | 3 | 1 | 0.03% | 0.72% | 1.20% | Q1 2017 | Q1 2019 | 4 |
| HSGX | HISTOGENICS | 4 | 4 | 0.28% | 0.71% | 1.04% | Q4 2014 | Q3 2015 | 4 |
| PGNX | PROGENICS PHARMACEUTIC... | 3 | 1 | 0.22% | 0.68% | 1.03% | Q1 2016 | Q1 2017 | 4 |
| RIGL | RIGEL PHARMACEUTICALS INC | 4 | 4 | 0.29% | 0.66% | 0.90% | Q3 2015 | Q2 2016 | 4 |
| ZGNX | ZOGENIX INC | 3 | 1 | 0.26% | 0.51% | 1.00% | Q1 2017 | Q2 2018 | 4 |
| IMMU | IMMUNOMEDICS INC | 3 | 1 | 0.06% | 0.49% | 1.67% | Q2 2016 | Q3 2017 | 4 |
| FENC | FENNEC PHARMACEUTICALS... | 4 | 4 | 0.46% | 0.48% | 0.50% | Q3 2017 | Q2 2018 | 4 |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 3 | 1 | 0.02% | 0.42% | 0.67% | Q2 2017 | Q2 2018 | 4 |
| GKOS | GLAUKOS CORP | 4 | 4 | 0.10% | 0.18% | 0.28% | Q2 2017 | Q1 2018 | 4 |
| NVAX | NOVAVAX INC | 4 | 4 | 0.08% | 0.16% | 0.20% | Q4 2020 | Q3 2021 | 4 |
| AKTX | AKARI THERAPEUTICS PLC | 4 | 4 | 0.07% | 0.13% | 0.21% | Q4 2015 | Q3 2016 | 4 |
| CBMX | COMBIMATRIX CORPORATION | 3 | 1 | 0.05% | 0.09% | 0.15% | Q1 2016 | Q3 2017 | 4 |
| MNKD | MANNKIND CORP | 4 | 4 | 0.02% | 0.06% | 0.14% | Q1 2016 | Q4 2016 | 4 |
| LRMR | LARIMAR THERAPEUTICS INC | 3 | 3 | 2.97% | 3.81% | 5.03% | Q2 2020 | Q4 2020 | 3 |
| OLED | UNIVERSAL DISPLAY CORP | 3 | 3 | 0.49% | 3.36% | 7.48% | Q4 2015 | Q2 2016 | 3 |
| EXEL | EXELIXIS INC | 3 | 3 | 0.72% | 3.36% | 6.11% | Q3 2015 | Q1 2016 | 3 |
| QQQ | POWERSHARES QQQ TRUST | 1 | 1 | 2.22% | 3.26% | 4.88% | Q4 2014 | Q1 2018 | 3 |
| CMPS | COMPASS PATHWAYS PLC | 3 | 3 | 1.20% | 3.01% | 4.14% | Q3 2020 | Q1 2021 | 3 |
| AGTC | APPLIED GENETIC TECHNO... | 2 | 1 | 0.04% | 2.94% | 7.09% | Q2 2015 | Q3 2016 | 3 |
| PTGX | PROTAGONIST THERAPEUTI... | 3 | 3 | 2.02% | 2.85% | 3.63% | Q1 2019 | Q3 2019 | 3 |
| LMAT | LEMAITRE VASCULAR | 3 | 3 | 1.86% | 2.52% | 3.29% | Q4 2014 | Q2 2015 | 3 |
| VINC | VINCERX PHARMA INC | 3 | 3 | 1.48% | 2.24% | 2.74% | Q1 2021 | Q3 2021 | 3 |
| CYT | CYTEIR THERAPEUTICS INC | 3 | 3 | 1.87% | 2.22% | 2.43% | Q2 2021 | Q4 2021 | 3 |
| LSACU | LIFESCI ACQUISITION CORP | 3 | 3 | 1.78% | 2.19% | 2.71% | Q1 2020 | Q3 2020 | 3 |
| RTRX | RETROPHIN INC | 3 | 3 | 0.84% | 1.93% | 3.41% | Q4 2015 | Q2 2016 | 3 |
| SPNC | SPECTRANETICS CORP | 2 | 1 | 0.25% | 1.86% | 3.56% | Q2 2015 | Q4 2016 | 3 |
| MDGL | MADRIGAL PHARMACEUTICA... | 2 | 1 | 0.98% | 1.75% | 2.52% | Q2 2018 | Q4 2020 | 3 |
| SURF | SURFACE ONCOLOGY INC | 3 | 3 | 0.43% | 1.66% | 2.51% | Q2 2020 | Q4 2020 | 3 |
| RAPT | RAPT THERAPEUTICS INC | 3 | 3 | 1.13% | 1.61% | 2.10% | Q3 2020 | Q1 2021 | 3 |
| INNL | INNOCOLL HLDGS PLC | 3 | 3 | 1.46% | 1.59% | 1.81% | Q1 2016 | Q3 2016 | 3 |
| ALKS | ALKERMES PLC | 3 | 3 | 0.66% | 1.33% | 2.38% | Q1 2023 | Q3 2023 | 3 |
| JNJ | JOHNSON & JOHNSON | 3 | 3 | 1.05% | 1.24% | 1.48% | Q1 2017 | Q3 2017 | 3 |
| OFIX | ORTHOFIX INTL N V | 2 | 1 | 0.46% | 1.21% | 1.81% | Q4 2014 | Q4 2015 | 3 |
| OLMA | OLEMA PHARMACEUTICALS INC | 2 | 1 | 0.65% | 1.13% | 1.46% | Q3 2021 | Q3 2023 | 3 |
| AVXS | AVEXIS INC | 2 | 1 | 1.01% | 1.11% | 1.21% | Q1 2017 | Q1 2018 | 3 |
| HILLEVAX INC | 3 | 3 | 0.08% | 1.08% | 2.44% | Q1 2023 | Q3 2023 | 3 | |
| RXDX | IGNYTA INC | 2 | 1 | 0.60% | 1.05% | 1.71% | Q4 2014 | Q2 2016 | 3 |
| SGNT | SAGENT PHARMACEUTICALS... | 3 | 3 | 0.42% | 1.05% | 1.62% | Q2 2015 | Q4 2015 | 3 |
| ENLIVEN THERAPEUTICS INC | 3 | 3 | 0.50% | 0.96% | 1.44% | Q1 2023 | Q3 2023 | 3 | |
| CNCE | CONCERT PHARMACEUTICAL... | 2 | 1 | 0.20% | 0.95% | 1.85% | Q1 2017 | Q4 2020 | 3 |
| VNDA | VANDA PHARMACEUTICALS INC | 2 | 1 | 0.12% | 0.88% | 1.54% | Q4 2015 | Q4 2016 | 3 |
| QURE | UNIQURE NV | 3 | 3 | 0.44% | 0.81% | 1.22% | Q4 2019 | Q2 2020 | 3 |
| FXI | ISHARES TR | 3 | 3 | 0.58% | 0.75% | 0.87% | Q3 2017 | Q1 2018 | 3 |
| FDMT | 4D MOLECULAR THERAPEUT... | 2 | 1 | 0.23% | 0.62% | 1.33% | Q4 2020 | Q1 2023 | 3 |
| AGRX | AGILE THERAPEUTICS | 3 | 3 | 0.55% | 0.62% | 0.68% | Q1 2015 | Q3 2015 | 3 |
| VCYT | VERACYTE INC | 3 | 3 | 0.28% | 0.58% | 1.08% | Q4 2016 | Q2 2017 | 3 |
| ALLK | ALLAKOS INC | 1 | 1 | 0.26% | 0.47% | 0.65% | Q1 2019 | Q3 2022 | 3 |
| NVTA | INVITAE CORP | 3 | 3 | 0.26% | 0.47% | 0.89% | Q2 2017 | Q4 2017 | 3 |
| AERI | AERIE PHARMACEUTICALS INC | 2 | 1 | 0.09% | 0.47% | 0.73% | Q2 2017 | Q2 2018 | 3 |
| MOLGY | MOL GLOBAL SPONSORED ADR | 3 | 3 | 0.14% | 0.44% | 0.70% | Q4 2014 | Q2 2015 | 3 |
| BCRX | BIOCRYST PHARMACEUTICALS | 3 | 3 | 0.18% | 0.35% | 0.65% | Q3 2016 | Q1 2017 | 3 |
| BMEA | BIOMEA FUSION INC | 2 | 1 | 0.00% | 0.32% | 0.60% | Q3 2022 | Q3 2023 | 3 |
| WVE | WAVE LIFE SCIENCES LTD | 3 | 3 | 0.23% | 0.27% | 0.32% | Q2 2020 | Q4 2020 | 3 |
| EVH | EVOLENT HEALTH INC | 2 | 1 | 0.08% | 0.25% | 0.42% | Q1 2017 | Q4 2017 | 3 |
| ZSAN | ZOSANO PHARMA | 3 | 3 | 0.17% | 0.25% | 0.39% | Q1 2015 | Q3 2015 | 3 |
| OSUR | ORASURE TECHNOLOGIES INC | 3 | 3 | 0.14% | 0.21% | 0.36% | Q4 2017 | Q2 2018 | 3 |
| TRXC | TRANSENTERIX INC | 3 | 3 | 0.02% | 0.04% | 0.05% | Q4 2017 | Q2 2018 | 3 |
| KNTE | KINNATE BIOPHARMA INC | 3 | 3 | 0.02% | 0.02% | 0.03% | Q3 2022 | Q1 2023 | 3 |
| BTAI | BIOXCEL THERAPEUTICS INC | 2 | 2 | 3.41% | 4.31% | 5.22% | Q1 2020 | Q2 2020 | 2 |
| DISC MEDICINE INC | 2 | 2 | 4.20% | 4.27% | 4.35% | Q2 2023 | Q3 2023 | 2 | |
| EXELIXIS INC | 2 | 2 | 2.44% | 2.98% | 3.51% | Q4 2014 | Q1 2015 | 2 | |
| SBBP | STRONGBRIDGE BIOPHARMA... | 2 | 2 | 2.52% | 2.90% | 3.28% | Q4 2015 | Q1 2016 | 2 |
| EPIX | ESSA PHARMA INC | 2 | 2 | 2.66% | 2.83% | 3.01% | Q1 2021 | Q2 2021 | 2 |
| CRSP | CRISPR THERAPEUTICS AG | 2 | 2 | 1.32% | 2.64% | 3.96% | Q2 2019 | Q3 2019 | 2 |
| AERI | AERIE PHARMACEUTICALS INC | 2 | 2 | 0.70% | 2.34% | 3.97% | Q3 2016 | Q4 2016 | 2 |
| KPTI | KARYOPHARM THERAPEUTIC... | 2 | 2 | 1.65% | 2.22% | 2.80% | Q3 2019 | Q4 2019 | 2 |
| CNST | CONSTELLATION PHARMCET... | 2 | 2 | 2.12% | 2.21% | 2.30% | Q4 2019 | Q1 2020 | 2 |
| CRIS | CURIS INC | 2 | 2 | 1.18% | 2.16% | 3.13% | Q4 2020 | Q1 2021 | 2 |
| BCAB | BIOATLA INC | 2 | 2 | 1.72% | 2.13% | 2.54% | Q3 2022 | Q4 2022 | 2 |
| REGN | REGENERON PHARMACEUTICALS | 2 | 2 | 1.23% | 2.06% | 2.88% | Q2 2018 | Q3 2018 | 2 |
| IKNA | IKENA ONCOLOGY INC | 2 | 2 | 1.60% | 2.04% | 2.48% | Q2 2023 | Q3 2023 | 2 |
| REPL | REPLIMUNE GROUP INC | 1 | 1 | 1.72% | 1.94% | 2.15% | Q4 2020 | Q3 2023 | 2 |
| SRNE | SORRENTO THERAPEUTICS | 2 | 2 | 1.46% | 1.89% | 2.31% | Q2 2015 | Q3 2015 | 2 |
| GWPH | GW PHARMACEUTICALS PLC | 2 | 2 | 1.66% | 1.86% | 2.07% | Q3 2016 | Q4 2016 | 2 |
| ADAP | ADAPTIMMUNE THERAPEUTI... | 1 | 1 | 0.34% | 1.85% | 3.37% | Q2 2015 | Q2 2020 | 2 |
| BMRN | BIOMARIN PHARMACEUTICA... | 2 | 2 | 1.04% | 1.72% | 2.39% | Q2 2016 | Q3 2016 | 2 |
| AXGT | AXOVANT SCIENCES | 2 | 2 | 1.05% | 1.59% | 2.14% | Q2 2015 | Q3 2015 | 2 |
| AVID | AVID TECHNOLOGY | 2 | 2 | 1.26% | 1.58% | 1.90% | Q1 2015 | Q2 2015 | 2 |
| LJPC | LA JOLLA PHARMACEUTICA... | 2 | 2 | 1.07% | 1.52% | 1.97% | Q3 2015 | Q4 2015 | 2 |
| JNCE | JOUNCE THERAPEUTICS INC | 2 | 2 | 0.45% | 1.51% | 2.58% | Q4 2021 | Q1 2022 | 2 |
| CHRS | COHERUS BIOSCIENCES INC | 2 | 2 | 0.86% | 1.47% | 2.08% | Q2 2018 | Q3 2018 | 2 |
| PODD | INSULET CORP | 1 | 1 | 1.09% | 1.42% | 1.75% | Q1 2015 | Q2 2016 | 2 |
| VERASTEM INC | 2 | 2 | 1.25% | 1.38% | 1.51% | Q2 2023 | Q3 2023 | 2 | |
| CYTK | CYTOKINETICS INC | 1 | 1 | 0.64% | 1.37% | 2.10% | Q2 2016 | Q3 2020 | 2 |
| BIOD | BIODEL | 2 | 2 | 0.65% | 1.24% | 1.84% | Q2 2015 | Q3 2015 | 2 |
| KROS | KEROS THERAPEUTICS INC | 2 | 2 | 0.11% | 1.24% | 2.36% | Q4 2022 | Q1 2023 | 2 |
| NBIX | NEUROCRINE BIOSCIENCES... | 1 | 1 | 0.92% | 1.22% | 1.52% | Q4 2015 | Q2 2016 | 2 |
| STOK | STOKE THERAPEUTICS INC | 2 | 2 | 0.63% | 1.09% | 1.56% | Q4 2020 | Q1 2021 | 2 |
| ANAB | ANAPTYSBIO INC | 2 | 2 | 0.98% | 1.05% | 1.11% | Q1 2017 | Q2 2017 | 2 |
| CLVS | CLOVIS ONCOLOGY INC | 1 | 1 | 0.80% | 0.99% | 1.18% | Q3 2015 | Q3 2017 | 2 |
| RAIN | RAIN THERAPEUTICS INC | 2 | 2 | 0.96% | 0.98% | 1.01% | Q2 2021 | Q3 2021 | 2 |
| EEM | ISHARES TR | 2 | 2 | 0.79% | 0.97% | 1.16% | Q1 2018 | Q2 2018 | 2 |
| ARWR | ARROWHEAD PHARMACEUTIC... | 2 | 2 | 0.48% | 0.93% | 1.37% | Q2 2018 | Q3 2018 | 2 |
| PACB | PACIFIC BIOSCIENCES CA... | 2 | 2 | 0.79% | 0.90% | 1.01% | Q1 2016 | Q2 2016 | 2 |
| CRDF | CARDIFF ONCOLOGY INC | 2 | 2 | 0.59% | 0.88% | 1.18% | Q2 2020 | Q3 2020 | 2 |
| ZYME | ZYMEWORKS INC | 2 | 2 | 0.79% | 0.87% | 0.94% | Q3 2019 | Q4 2019 | 2 |
| CERS | CERUS | 2 | 2 | 0.35% | 0.83% | 1.30% | Q4 2014 | Q1 2015 | 2 |
| EGOV | NIC | 2 | 2 | 0.79% | 0.82% | 0.85% | Q1 2015 | Q2 2015 | 2 |
| BLCM | BELLICUM PHARMACEUTICALS | 2 | 2 | 0.71% | 0.78% | 0.86% | Q4 2014 | Q1 2015 | 2 |
| CDTX | CIDARA THERAPEUTICS | 2 | 2 | 0.44% | 0.78% | 1.13% | Q2 2015 | Q3 2015 | 2 |
| VKTX | VIKING THERAPEUTICS INC | 1 | 1 | 0.17% | 0.72% | 1.27% | Q2 2018 | Q1 2023 | 2 |
| DYN | DYNE THERAPEUTICS INC | 2 | 2 | 0.56% | 0.72% | 0.88% | Q2 2023 | Q3 2023 | 2 |
| GHDX | GENOMIC HEALTH INC | 2 | 2 | 0.61% | 0.70% | 0.78% | Q2 2016 | Q3 2016 | 2 |
| OTIC | OTONOMY | 2 | 2 | 0.60% | 0.68% | 0.76% | Q1 2015 | Q2 2015 | 2 |
| CCCC | C4 THERAPEUTICS STK | 1 | 1 | 0.33% | 0.66% | 0.99% | Q4 2020 | Q3 2021 | 2 |
| MRNS | MARINUS PHARMACEUTICAL... | 1 | 1 | 0.27% | 0.65% | 1.02% | Q1 2015 | Q1 2020 | 2 |
| REPH | RECRO PHARMA INC | 1 | 1 | 0.40% | 0.65% | 0.90% | Q4 2016 | Q2 2017 | 2 |
| MDCO | MEDICINES CO | 1 | 1 | 0.46% | 0.63% | 0.81% | Q1 2017 | Q4 2019 | 2 |
| SGEN | SEATTLE GENETICS INC | 2 | 2 | 0.39% | 0.60% | 0.81% | Q3 2017 | Q4 2017 | 2 |
| ATRC | ATRICURE INC | 2 | 2 | 0.39% | 0.58% | 0.77% | Q2 2016 | Q3 2016 | 2 |
| MGTA | MAGENTA THERAPEUTICS INC | 2 | 2 | 0.41% | 0.57% | 0.73% | Q2 2018 | Q3 2018 | 2 |
| CLVS | CLOVIS ONCOLOGY INC | 2 | 2 | 0.52% | 0.57% | 0.61% | Q1 2017 | Q2 2017 | 2 |
| AERI | AERIE PHARMACEUTICALS INC | 1 | 1 | 0.27% | 0.56% | 0.84% | Q3 2016 | Q1 2018 | 2 |
| ANNX | ANNEXON INC | 2 | 2 | 0.17% | 0.54% | 0.90% | Q3 2020 | Q4 2020 | 2 |
| MTEM | MOLECULAR TEMPLATES INC | 2 | 2 | 0.50% | 0.51% | 0.53% | Q4 2021 | Q1 2022 | 2 |
| EXEL | EXELIXIS INC | 1 | 1 | 0.29% | 0.50% | 0.71% | Q1 2015 | Q4 2017 | 2 |
| KRON | KRONOS BIO INC | 2 | 2 | 0.37% | 0.50% | 0.63% | Q2 2023 | Q3 2023 | 2 |
| SGEN | SEATTLE GENETICS INC | 2 | 2 | 0.30% | 0.49% | 0.68% | Q3 2017 | Q4 2017 | 2 |
| LCI | LANNET INC | 2 | 2 | 0.42% | 0.47% | 0.51% | Q2 2017 | Q3 2017 | 2 |
| EXEL | EXELIXIS INC | 1 | 1 | 0.44% | 0.46% | 0.48% | Q4 2016 | Q2 2017 | 2 |
| CPRX | CATALYST PHARMACEUTICA... | 2 | 2 | 0.13% | 0.44% | 0.76% | Q1 2021 | Q2 2021 | 2 |
| GNVC | GENVEC | 2 | 2 | 0.38% | 0.44% | 0.50% | Q4 2014 | Q1 2015 | 2 |
| SVA | SINOVAC BIOTECH LTD | 2 | 2 | 0.38% | 0.42% | 0.45% | Q2 2016 | Q3 2016 | 2 |
| AVEO | AVEO PHARMACEUTICALS INC | 1 | 1 | 0.07% | 0.40% | 0.72% | Q1 2015 | Q4 2017 | 2 |
| NKTR | NEKTAR THERAPEUTICS | 1 | 1 | 0.34% | 0.38% | 0.43% | Q1 2017 | Q4 2017 | 2 |
| SVRA | SAVARA INC | 2 | 2 | 0.29% | 0.36% | 0.43% | Q1 2023 | Q2 2023 | 2 |
| THC | TENET HEALTHCARE CORP | 1 | 1 | 0.28% | 0.35% | 0.41% | Q4 2015 | Q3 2016 | 2 |
| EDIT | EDITAS MEDICINE INC | 1 | 1 | 0.32% | 0.34% | 0.37% | Q4 2017 | Q2 2018 | 2 |
| AEGERION PHARMACEUTICA... | 2 | 2 | 0.28% | 0.30% | 0.32% | Q4 2015 | Q1 2016 | 2 | |
| STRO | SUTRO BIOPHARMA INC | 2 | 2 | 0.25% | 0.28% | 0.31% | Q4 2018 | Q1 2019 | 2 |
| EDIT | EDITAS MEDICINE INC | 2 | 2 | 0.23% | 0.26% | 0.30% | Q4 2017 | Q1 2018 | 2 |
| SMLR | SEMLER SCIENTIFIC | 2 | 2 | 0.16% | 0.25% | 0.34% | Q1 2015 | Q2 2015 | 2 |
| VSAR | VERSARTIS INC | 2 | 2 | 0.24% | 0.24% | 0.25% | Q1 2017 | Q2 2017 | 2 |
| LBIO | LION BIOTECHNOLOGIES INC | 2 | 2 | 0.07% | 0.23% | 0.39% | Q4 2016 | Q1 2017 | 2 |
| GOGO | GOGO INC | 2 | 2 | 0.16% | 0.22% | 0.29% | Q2 2017 | Q3 2017 | 2 |
| TDOC | TELADOC INC | 2 | 2 | 0.18% | 0.22% | 0.26% | Q3 2017 | Q4 2017 | 2 |
| CHRS | COHERUS BIOSCIENCES INC | 2 | 2 | 0.12% | 0.21% | 0.29% | Q2 2018 | Q3 2018 | 2 |
| IMGN | IMMUNOGEN INC | 1 | 1 | 0.12% | 0.20% | 0.29% | Q1 2022 | Q3 2022 | 2 |
| DICE THERAPEUTICS INC | 1 | 1 | 0.06% | 0.20% | 0.34% | Q1 2022 | Q3 2022 | 2 | |
| AXDX | ACCELERATE DIAGNOSTICS... | 1 | 1 | 0.14% | 0.19% | 0.24% | Q3 2015 | Q3 2017 | 2 |
| ENDOLOGIX INC | 1 | 1 | 0.03% | 0.18% | 0.32% | Q1 2016 | Q4 2016 | 2 | |
| EVTC | EVERTEC INC | 2 | 2 | 0.14% | 0.17% | 0.20% | Q3 2017 | Q4 2017 | 2 |
| DBVT | DBV TECHNOLOGIES S A | 1 | 1 | 0.07% | 0.16% | 0.25% | Q1 2017 | Q3 2017 | 2 |
| ARDX | ARDELYX INC | 2 | 2 | 0.13% | 0.13% | 0.14% | Q3 2016 | Q4 2016 | 2 |
| MDXG | MIMEDX GROUP INC | 2 | 2 | 0.12% | 0.13% | 0.15% | Q3 2017 | Q4 2017 | 2 |
| TROV | TROVAGENE INC | 2 | 2 | 0.11% | 0.12% | 0.14% | Q2 2016 | Q3 2016 | 2 |
| SGMO | SANGAMO THERAPEUTICS INC | 1 | 1 | 0.07% | 0.11% | 0.16% | Q2 2017 | Q1 2018 | 2 |
| DXTRQ | DEXTERA SURGICAL INC | 2 | 2 | 0.09% | 0.10% | 0.11% | Q2 2016 | Q3 2016 | 2 |
| LXRX | LEXICON PHARMACEUTICAL... | 2 | 2 | 0.06% | 0.07% | 0.09% | Q3 2017 | Q4 2017 | 2 |
| SWTX | SPRINGWORKS THERAPEUTI... | 2 | 2 | 0.06% | 0.07% | 0.07% | Q2 2022 | Q3 2022 | 2 |
| NUVB | NUVATION WARRANTS | 2 | 2 | 0.03% | 0.05% | 0.07% | Q4 2021 | Q1 2022 | 2 |
| TRVI | TREVI THERAPEUTICS INC | 2 | 2 | 0.02% | 0.04% | 0.06% | Q2 2022 | Q3 2022 | 2 |
| PTX | PERNIX THERAPEUTICS HL... | 2 | 2 | 0.01% | 0.02% | 0.02% | Q2 2016 | Q3 2016 | 2 |
| TSHA | TAYSHA GENE THERAPIES INC | 1 | 1 | 8.11% | 8.11% | 8.11% | Q3 2023 | Q3 2023 | 1 |
| CLDX | CELLDEX THERAPEUTICS I... | 1 | 1 | 6.68% | 6.68% | 6.68% | Q2 2021 | Q2 2021 | 1 |
| RAYZEBIO INC | 1 | 1 | 5.13% | 5.13% | 5.13% | Q3 2023 | Q3 2023 | 1 | |
| ITCI | INTRA CELLULAR THERAPI... | 1 | 1 | 4.99% | 4.99% | 4.99% | Q4 2019 | Q4 2019 | 1 |
| IMMU | IMMUNOMEDICS INC | 1 | 1 | 4.35% | 4.35% | 4.35% | Q4 2018 | Q4 2018 | 1 |
| ATNX | ATHENEX INC | 1 | 1 | 3.33% | 3.33% | 3.33% | Q2 2019 | Q2 2019 | 1 |
| RLMD | RELMADA THERAPEUTICS INC | 1 | 1 | 3.19% | 3.19% | 3.19% | Q3 2022 | Q3 2022 | 1 |
| CPXX | CELATOR PHARMACEUTICAL... | 1 | 1 | 3.08% | 3.08% | 3.08% | Q1 2016 | Q1 2016 | 1 |
| ROCHE GS | 1 | 1 | 2.97% | 2.97% | 2.97% | Q2 2022 | Q2 2022 | 1 | |
| OLED | UNIVERSAL DISPLAY CORP | 1 | 1 | 2.95% | 2.95% | 2.95% | Q4 2015 | Q4 2015 | 1 |
| IVERIC BIO INC | 1 | 1 | 2.69% | 2.69% | 2.69% | Q1 2023 | Q1 2023 | 1 | |
| CELLDEX THERAPEUTICS INC | 1 | 1 | 2.65% | 2.65% | 2.65% | Q1 2023 | Q1 2023 | 1 | |
| CEMP | CEMPRA | 1 | 1 | 2.62% | 2.62% | 2.62% | Q4 2014 | Q4 2014 | 1 |
| CLNN | CLENE INC | 1 | 1 | 2.53% | 2.53% | 2.53% | Q2 2023 | Q2 2023 | 1 |
| LXRX | LEXICON PHARMACEUTICALS | 1 | 1 | 2.49% | 2.49% | 2.49% | Q3 2015 | Q3 2015 | 1 |
| WBMD | WEBMD HEALTH CORP | 1 | 1 | 2.37% | 2.37% | 2.37% | Q1 2017 | Q1 2017 | 1 |
| RCUS | ARCUS BIOSCIENCES INC | 1 | 1 | 2.36% | 2.36% | 2.36% | Q2 2022 | Q2 2022 | 1 |
| INCY | INCYTE CORP | 1 | 1 | 2.29% | 2.29% | 2.29% | Q4 2015 | Q4 2015 | 1 |
| KITE | KITE PHARMA INC | 1 | 1 | 2.18% | 2.18% | 2.18% | Q2 2017 | Q2 2017 | 1 |
| TTPH | TETRAPHASE PHARMACEUTI... | 1 | 1 | 2.01% | 2.01% | 2.01% | Q4 2014 | Q4 2014 | 1 |
| AVADEL PHARMACEUTICALS... | 1 | 1 | 1.97% | 1.97% | 1.97% | Q4 2021 | Q4 2021 | 1 | |
| CTIC | CTI BIOPHARMA | 1 | 1 | 1.96% | 1.96% | 1.96% | Q4 2014 | Q4 2014 | 1 |
| CRNX | CRINETICS PHARMACEUTIC... | 1 | 1 | 1.87% | 1.87% | 1.87% | Q3 2023 | Q3 2023 | 1 |
| 5100PS | VOLCANO CORPORATION | 1 | 1 | 1.85% | 1.85% | 1.85% | Q4 2014 | Q4 2014 | 1 |
| DTIL | PRECISION BIOSCIENCES INC | 1 | 1 | 1.83% | 1.83% | 1.83% | Q2 2022 | Q2 2022 | 1 |
| IG | IGI LABS | 1 | 1 | 1.80% | 1.80% | 1.80% | Q2 2015 | Q2 2015 | 1 |
| IGI LABORATORIES INC | 1 | 1 | 1.78% | 1.78% | 1.78% | Q1 2016 | Q1 2016 | 1 | |
| ALEC | ALECTOR INC | 1 | 1 | 1.78% | 1.78% | 1.78% | Q1 2019 | Q1 2019 | 1 |
| SPECTRANETICS CORP | 1 | 1 | 1.75% | 1.75% | 1.75% | Q3 2015 | Q3 2015 | 1 | |
| ALGS | ALIGOS THERAPEUTICS INC | 1 | 1 | 1.75% | 1.75% | 1.75% | Q2 2021 | Q2 2021 | 1 |
| SPY | SPDR S&P 500 ETF TR | 1 | 1 | 1.74% | 1.74% | 1.74% | Q1 2015 | Q1 2015 | 1 |
| VRTX | VERTEX PHARMACEUTICALS | 1 | 1 | 1.61% | 1.61% | 1.61% | Q4 2014 | Q4 2014 | 1 |
| RCPT | RECEPTOS | 1 | 1 | 1.55% | 1.55% | 1.55% | Q4 2014 | Q4 2014 | 1 |
| ONTY | ONCOTHYREON | 1 | 1 | 1.55% | 1.55% | 1.55% | Q2 2015 | Q2 2015 | 1 |
| DBVT | DBV TECHNOLOGIES S A | 1 | 1 | 1.52% | 1.52% | 1.52% | Q3 2017 | Q3 2017 | 1 |
| VIR | VIR BIOTECHNOLOGY INC | 1 | 1 | 1.50% | 1.50% | 1.50% | Q2 2020 | Q2 2020 | 1 |
| ROIVANT SCIENCES LTD | 1 | 1 | 1.50% | 1.50% | 1.50% | Q2 2023 | Q2 2023 | 1 | |
| HZNP | HORIZON PHARMA PLC | 1 | 1 | 1.46% | 1.46% | 1.46% | Q4 2014 | Q4 2014 | 1 |
| MDVN | MEDIVATION INC | 1 | 1 | 1.45% | 1.45% | 1.45% | Q2 2016 | Q2 2016 | 1 |
| COLL | COLLEGIUM PHARMACEUTICAL | 1 | 1 | 1.43% | 1.43% | 1.43% | Q2 2015 | Q2 2015 | 1 |
| CNTA | CENTESSA PHARMACEUTICA... | 1 | 1 | 1.40% | 1.40% | 1.40% | Q3 2023 | Q3 2023 | 1 |
| VASC | VASCULAR SOLUTIONS | 1 | 1 | 1.37% | 1.37% | 1.37% | Q4 2014 | Q4 2014 | 1 |
| ALPN | ALPINE IMMUNE SCIENCES... | 1 | 1 | 1.34% | 1.34% | 1.34% | Q4 2021 | Q4 2021 | 1 |
| KRYS | KRYSTAL BIOTECH | 1 | 1 | 1.34% | 1.34% | 1.34% | Q3 2021 | Q3 2021 | 1 |
| CABA | CABALETTA BIO | 1 | 1 | 1.30% | 1.30% | 1.30% | Q3 2021 | Q3 2021 | 1 |
| ARRY | ARRAY BIOPHARMA | 1 | 1 | 1.27% | 1.27% | 1.27% | Q3 2015 | Q3 2015 | 1 |
| ATRA | ATARA BIOTHERAPEUTICS INC | 1 | 1 | 1.20% | 1.20% | 1.20% | Q4 2015 | Q4 2015 | 1 |
| REPL | REPLIMUNE GROUP INC | 1 | 1 | 1.18% | 1.18% | 1.18% | Q3 2023 | Q3 2023 | 1 |
| EHTH | EHEALTH | 1 | 1 | 1.17% | 1.17% | 1.17% | Q4 2014 | Q4 2014 | 1 |
| HARP | HARPOON THERAPEUTICS INC | 1 | 1 | 1.16% | 1.16% | 1.16% | Q1 2022 | Q1 2022 | 1 |
| OBSV | OBSEVA SA | 1 | 1 | 1.14% | 1.14% | 1.14% | Q2 2018 | Q2 2018 | 1 |
| NLTX | NEOLEUKIN THERAPEUTICS... | 1 | 1 | 1.14% | 1.14% | 1.14% | Q4 2019 | Q4 2019 | 1 |
| FRSH | PAPA MURPHYS HLDGS | 1 | 1 | 1.10% | 1.10% | 1.10% | Q4 2014 | Q4 2014 | 1 |
| TNDM | TANDEM DIABETES CARE INC | 1 | 1 | 1.09% | 1.09% | 1.09% | Q1 2018 | Q1 2018 | 1 |
| EPZM | EPIZYME | 1 | 1 | 1.04% | 1.04% | 1.04% | Q3 2015 | Q3 2015 | 1 |
| ETNB | 89BIO INC | 1 | 1 | 1.02% | 1.02% | 1.02% | Q3 2023 | Q3 2023 | 1 |
| DEPO | DEPOMED | 1 | 1 | 0.99% | 0.99% | 0.99% | Q4 2014 | Q4 2014 | 1 |
| CATABASIS PHARMACEUTIC... | 1 | 1 | 0.99% | 0.99% | 0.99% | Q2 2021 | Q2 2021 | 1 | |
| HPTX | HYPERION THERAPEUTICS | 1 | 1 | 0.98% | 0.98% | 0.98% | Q4 2014 | Q4 2014 | 1 |
| PMVP | CALL- PMVP 100 @ 20 EX... | 1 | 1 | 0.97% | 0.97% | 0.97% | Q1 2022 | Q1 2022 | 1 |
| GBT | GLOBAL BLOOD THERAPEUT... | 1 | 1 | 0.97% | 0.97% | 0.97% | Q1 2020 | Q1 2020 | 1 |
| LLY | LILLY ELI & CO | 1 | 1 | 0.95% | 0.95% | 0.95% | Q1 2018 | Q1 2018 | 1 |
| NEURODERM LTD | 1 | 1 | 0.94% | 0.94% | 0.94% | Q1 2017 | Q1 2017 | 1 | |
| AGN | ALLERGAN PLC | 1 | 1 | 0.94% | 0.94% | 0.94% | Q2 2016 | Q2 2016 | 1 |
| GWPH | GW PHARMACEUTICALS PLC | 1 | 1 | 0.92% | 0.92% | 0.92% | Q4 2014 | Q4 2014 | 1 |
| PANAU | PANACEA ACQUISITION CORP | 1 | 1 | 0.91% | 0.91% | 0.91% | Q3 2020 | Q3 2020 | 1 |
| TAST | CARROLS RESTAURANT GROUP | 1 | 1 | 0.89% | 0.89% | 0.89% | Q3 2015 | Q3 2015 | 1 |
| PTCT | PTC THERAPEUTICS INC | 1 | 1 | 0.88% | 0.88% | 0.88% | Q3 2019 | Q3 2019 | 1 |
| AVDL | AVADEL PHARMACEUTICALS... | 1 | 1 | 0.86% | 0.86% | 0.86% | Q3 2021 | Q3 2021 | 1 |
| FWP | FORWARD PHARMA A/S | 1 | 1 | 0.86% | 0.86% | 0.86% | Q4 2014 | Q4 2014 | 1 |
| ITCI | INTRA CELLULAR THERAPI... | 1 | 1 | 0.85% | 0.85% | 0.85% | Q4 2019 | Q4 2019 | 1 |
| CERS | CERUS | 1 | 1 | 0.84% | 0.84% | 0.84% | Q4 2014 | Q4 2014 | 1 |
| HTWR | HEARTWARE INTL INC | 1 | 1 | 0.83% | 0.83% | 0.83% | Q4 2015 | Q4 2015 | 1 |
| ARRAY BIOPHARMA INC | 1 | 1 | 0.83% | 0.83% | 0.83% | Q4 2014 | Q4 2014 | 1 | |
| MNTA | MOMENTA PHARMACEUTICAL... | 1 | 1 | 0.82% | 0.82% | 0.82% | Q4 2017 | Q4 2017 | 1 |
| RDUS | RADIUS HEALTH INC | 1 | 1 | 0.81% | 0.81% | 0.81% | Q3 2016 | Q3 2016 | 1 |
| EIGR | EIGER BIOPHARMACEUTICA... | 1 | 1 | 0.81% | 0.81% | 0.81% | Q2 2020 | Q2 2020 | 1 |
| NXTM | NXSTAGE MEDICAL | 1 | 1 | 0.78% | 0.78% | 0.78% | Q1 2015 | Q1 2015 | 1 |
| SRNE | SORRENTO THERAPEUTICS | 1 | 1 | 0.78% | 0.78% | 0.78% | Q1 2015 | Q1 2015 | 1 |
| BHVN | BIOHAVEN PHARMACTL HLD... | 1 | 1 | 0.78% | 0.78% | 0.78% | Q2 2019 | Q2 2019 | 1 |
| NSTG | NANOSTRING TECHNOLOGIE... | 1 | 1 | 0.78% | 0.78% | 0.78% | Q1 2017 | Q1 2017 | 1 |
| AMAG | AMAG PHARMACEUTICALS | 1 | 1 | 0.77% | 0.77% | 0.77% | Q4 2014 | Q4 2014 | 1 |
| PRTK | PARATEK PHARMACEUTICALS | 1 | 1 | 0.76% | 0.76% | 0.76% | Q4 2014 | Q4 2014 | 1 |
| VINCW | VINCERX PHARMA INC | 1 | 1 | 0.76% | 0.76% | 0.76% | Q1 2021 | Q1 2021 | 1 |
| ZINCQ | HORSEHEAD HLDG | 1 | 1 | 0.73% | 0.73% | 0.73% | Q4 2014 | Q4 2014 | 1 |
| ALR | ALERE INC | 1 | 1 | 0.73% | 0.73% | 0.73% | Q3 2016 | Q3 2016 | 1 |
| ITOS | ITEOS THERAPEUTICS INC | 1 | 1 | 0.71% | 0.71% | 0.71% | Q2 2022 | Q2 2022 | 1 |
| HUM | HUMANA | 1 | 1 | 0.71% | 0.71% | 0.71% | Q2 2015 | Q2 2015 | 1 |
| DYAX | DYAX CORP | 1 | 1 | 0.71% | 0.71% | 0.71% | Q1 2015 | Q1 2015 | 1 |
| HRTX | HERON THERAPEUTICS | 1 | 1 | 0.69% | 0.69% | 0.69% | Q4 2014 | Q4 2014 | 1 |
| BDSI | BIODELIVERY SCIENCES INTL | 1 | 1 | 0.68% | 0.68% | 0.68% | Q3 2015 | Q3 2015 | 1 |
| FUSN | FUSION PHARMACEUTICALS... | 1 | 1 | 0.68% | 0.68% | 0.68% | Q2 2020 | Q2 2020 | 1 |
| MORF | MORPHIC HOLDING INC | 1 | 1 | 0.68% | 0.68% | 0.68% | Q2 2023 | Q2 2023 | 1 |
| JUNO | JUNO THERAPEUTICS INC | 1 | 1 | 0.67% | 0.67% | 0.67% | Q2 2017 | Q2 2017 | 1 |
| ZGNX | ZOGENIX INC | 1 | 1 | 0.65% | 0.65% | 0.65% | Q2 2018 | Q2 2018 | 1 |
| CEMP | CEMPRA | 1 | 1 | 0.64% | 0.64% | 0.64% | Q4 2014 | Q4 2014 | 1 |
| ATHA | CALL- ATHA 100@12 1/2 ... | 1 | 1 | 0.63% | 0.63% | 0.63% | Q1 2022 | Q1 2022 | 1 |
| SGY | STONE ENERGY CORP | 1 | 1 | 0.63% | 0.63% | 0.63% | Q2 2016 | Q2 2016 | 1 |
| SRRA | SIERRA ONCOLOGY INC | 1 | 1 | 0.63% | 0.63% | 0.63% | Q4 2021 | Q4 2021 | 1 |
| MEIP | MEI PHARMA INC | 1 | 1 | 0.62% | 0.62% | 0.62% | Q2 2018 | Q2 2018 | 1 |
| GBIO | GENERATION BIO CO | 1 | 1 | 0.61% | 0.61% | 0.61% | Q2 2020 | Q2 2020 | 1 |
| MOONLAKE IMMUNOTHERAPE... | 1 | 1 | 0.60% | 0.60% | 0.60% | Q4 2022 | Q4 2022 | 1 | |
| GBT | GLOBAL BLOOD THERAPEUT... | 1 | 1 | 0.59% | 0.59% | 0.59% | Q4 2017 | Q4 2017 | 1 |
| DHR | DANAHER CORPORATION | 1 | 1 | 0.58% | 0.58% | 0.58% | Q2 2019 | Q2 2019 | 1 |
| ECYT | ENDOCYTE INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q3 2018 | Q3 2018 | 1 |
| ZBH | ZIMMER BIOMET HLDGS INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q4 2016 | Q4 2016 | 1 |
| FUN | CEDAR FAIR L P | 1 | 1 | 0.58% | 0.58% | 0.58% | Q4 2015 | Q4 2015 | 1 |
| CRBP | CORBUS PHARMACEUTICALS... | 1 | 1 | 0.57% | 0.57% | 0.57% | Q1 2017 | Q1 2017 | 1 |
| TOCA | TOCAGEN INC | 1 | 1 | 0.56% | 0.56% | 0.56% | Q3 2017 | Q3 2017 | 1 |
| BCYC | BICYCLE THERAPEUTICS P... | 1 | 1 | 0.56% | 0.56% | 0.56% | Q3 2021 | Q3 2021 | 1 |
| BCLI | BRAINSTORM CELL THERAP... | 1 | 1 | 0.55% | 0.55% | 0.55% | Q3 2023 | Q3 2023 | 1 |
| INOTEK PHARMACEUTICALS... | 1 | 1 | 0.54% | 0.54% | 0.54% | Q2 2018 | Q2 2018 | 1 | |
| MRVL | MARVELL TECHNOLOGY GRO... | 1 | 1 | 0.53% | 0.53% | 0.53% | Q1 2017 | Q1 2017 | 1 |
| EWA | ISHARES | 1 | 1 | 0.52% | 0.52% | 0.52% | Q3 2015 | Q3 2015 | 1 |
| SRPT | SAREPTA THERAPEUTICS INC | 1 | 1 | 0.51% | 0.51% | 0.51% | Q4 2016 | Q4 2016 | 1 |
| GRTX | GALERA THERAPEUTICS INC | 1 | 1 | 0.51% | 0.51% | 0.51% | Q4 2021 | Q4 2021 | 1 |
| CLVS | CLOVIS ONCOLOGY INC | 1 | 1 | 0.50% | 0.50% | 0.50% | Q4 2015 | Q4 2015 | 1 |
| CLDN | CELLADON | 1 | 1 | 0.50% | 0.50% | 0.50% | Q3 2015 | Q3 2015 | 1 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1 | 1 | 0.50% | 0.50% | 0.50% | Q3 2016 | Q3 2016 | 1 |
| ATHN | ATHENAHEALTH | 1 | 1 | 0.49% | 0.49% | 0.49% | Q4 2014 | Q4 2014 | 1 |
| ASTRIA THERAPEUTICS | 1 | 1 | 0.49% | 0.49% | 0.49% | Q3 2021 | Q3 2021 | 1 | |
| ARMO | ARMO BIOSCIENCES INC | 1 | 1 | 0.49% | 0.49% | 0.49% | Q1 2018 | Q1 2018 | 1 |
| AWAY | HOMEAWAY | 1 | 1 | 0.48% | 0.48% | 0.48% | Q2 2015 | Q2 2015 | 1 |
| LOXO | LOXO ONCOLOGY INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q4 2017 | Q4 2017 | 1 |
| NBIX | NEUROCRINE BIOSCIENCES | 1 | 1 | 0.48% | 0.48% | 0.48% | Q4 2014 | Q4 2014 | 1 |
| ONCR | ONCORUS INC | 1 | 1 | 0.47% | 0.47% | 0.47% | Q4 2020 | Q4 2020 | 1 |
| VSAR | VERSARTIS | 1 | 1 | 0.47% | 0.47% | 0.47% | Q2 2015 | Q2 2015 | 1 |
| INOTEK PHARMACEUTICALS... | 1 | 1 | 0.47% | 0.47% | 0.47% | Q1 2018 | Q1 2018 | 1 | |
| UTHR | UNITED THERAPEUTICS CO... | 1 | 1 | 0.46% | 0.46% | 0.46% | Q1 2018 | Q1 2018 | 1 |
| RPTP | RAPTOR PHARMACEUTICAL ... | 1 | 1 | 0.45% | 0.45% | 0.45% | Q2 2016 | Q2 2016 | 1 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1 | 1 | 0.43% | 0.43% | 0.43% | Q4 2017 | Q4 2017 | 1 |
| SPNC | SPECTRANETICS CORP | 1 | 1 | 0.43% | 0.43% | 0.43% | Q2 2017 | Q2 2017 | 1 |
| FOLD | AMICUS THERAPEUTICS INC | 1 | 1 | 0.41% | 0.41% | 0.41% | Q3 2017 | Q3 2017 | 1 |
| NKTR | NEKTAR THERAPEUTICS | 1 | 1 | 0.41% | 0.41% | 0.41% | Q4 2017 | Q4 2017 | 1 |
| ATRS | ANTARES PHARMA | 1 | 1 | 0.40% | 0.40% | 0.40% | Q4 2014 | Q4 2014 | 1 |
| RARE | ULTRAGENYX PHARMACEUTI... | 1 | 1 | 0.40% | 0.40% | 0.40% | Q4 2017 | Q4 2017 | 1 |
| DSCO | DISCOVERY LABORATORIES | 1 | 1 | 0.39% | 0.39% | 0.39% | Q1 2015 | Q1 2015 | 1 |
| VRX | VALEANT PHARMACEUTICAL... | 1 | 1 | 0.39% | 0.39% | 0.39% | Q4 2017 | Q4 2017 | 1 |
| SQNM | SEQUENOM | 1 | 1 | 0.39% | 0.39% | 0.39% | Q4 2014 | Q4 2014 | 1 |
| NSPH | NANOSPHERE | 1 | 1 | 0.39% | 0.39% | 0.39% | Q4 2014 | Q4 2014 | 1 |
| QLTI | QLT INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q4 2015 | Q4 2015 | 1 |
| ALXN | ALEXION PHARMACEUTICAL... | 1 | 1 | 0.38% | 0.38% | 0.38% | Q3 2017 | Q3 2017 | 1 |
| ACST | ACASTI PHARMA INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q4 2019 | Q4 2019 | 1 |
| AZN | ASTRAZENECA PLC | 1 | 1 | 0.37% | 0.37% | 0.37% | Q3 2016 | Q3 2016 | 1 |
| CRSP | CRISPR THERAPEUTICS AG | 1 | 1 | 0.36% | 0.36% | 0.36% | Q4 2017 | Q4 2017 | 1 |
| CNC | CENTENE CORP DEL | 1 | 1 | 0.35% | 0.35% | 0.35% | Q3 2017 | Q3 2017 | 1 |
| PRTA | PROTHENA CORPORATION PLC | 1 | 1 | 0.34% | 0.34% | 0.34% | Q4 2022 | Q4 2022 | 1 |
| NITE | NIGHTSTAR THERAPEUTICS... | 1 | 1 | 0.34% | 0.34% | 0.34% | Q3 2017 | Q3 2017 | 1 |
| IONS | IONIS PHARMACEUTICALS INC | 1 | 1 | 0.34% | 0.34% | 0.34% | Q3 2023 | Q3 2023 | 1 |
| CCXI | CHEMOCENTRYX INC | 1 | 1 | 0.34% | 0.34% | 0.34% | Q4 2019 | Q4 2019 | 1 |
| PSDV | PSIVIDA | 1 | 1 | 0.34% | 0.34% | 0.34% | Q4 2014 | Q4 2014 | 1 |
| SAGE | SAGE THERAPEUTICS INC | 1 | 1 | 0.34% | 0.34% | 0.34% | Q1 2017 | Q1 2017 | 1 |
| PGNX | PROGENICS PHARMACEUTIC... | 1 | 1 | 0.34% | 0.34% | 0.34% | Q1 2017 | Q1 2017 | 1 |
| LEAP THERAPEUTICS INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q3 2023 | Q3 2023 | 1 | |
| VCEL | VERICEL CORP | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2018 | Q2 2018 | 1 |
| ELAN | ELANCO ANIMAL HEALTH | 1 | 1 | 0.33% | 0.33% | 0.33% | Q3 2021 | Q3 2021 | 1 |
| CYCC | CYCLACEL PHARMACEUTICA... | 1 | 1 | 0.32% | 0.32% | 0.32% | Q4 2020 | Q4 2020 | 1 |
| JUNO | JUNO THERAPEUTICS INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q4 2017 | Q4 2017 | 1 |
| IRWD | IRONWOOD PHARMACEUTICA... | 1 | 1 | 0.31% | 0.31% | 0.31% | Q2 2016 | Q2 2016 | 1 |
| NTLA | INTELLIA THERAPEUTICS INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q4 2017 | Q4 2017 | 1 |
| STML | STEMLINE THERAPEUTICS INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q4 2017 | Q4 2017 | 1 |
| KZR | KEZAR LIFE SCIENCES INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q2 2018 | Q2 2018 | 1 |
| ELOS | SYNERON MEDICAL LTD | 1 | 1 | 0.31% | 0.31% | 0.31% | Q1 2017 | Q1 2017 | 1 |
| STSA | SATSUMA PHARMACEUTICAL... | 1 | 1 | 0.29% | 0.29% | 0.29% | Q2 2020 | Q2 2020 | 1 |
| ADVM | ADVERUM BIOTECHNOLOGIE... | 1 | 1 | 0.28% | 0.28% | 0.28% | Q4 2019 | Q4 2019 | 1 |
| TLGT | TELIGENT INC NEW | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2016 | Q1 2016 | 1 |
| DB | DEUTSCHE BANK AG | 1 | 1 | 0.28% | 0.28% | 0.28% | Q2 2018 | Q2 2018 | 1 |
| ALCOBRA SHS | 1 | 1 | 0.28% | 0.28% | 0.28% | Q2 2015 | Q2 2015 | 1 | |
| ABEO | ABEONA THERAPEUTICS | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2015 | Q3 2015 | 1 |
| ZIOP | ZIOPHARM ONCOLOGY INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q2 2017 | Q2 2017 | 1 |
| UMRX | UNUM THERAPEUTICS INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2020 | Q3 2020 | 1 |
| AIMT | AIMMUNE THERAPEUTICS INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2017 | Q3 2017 | 1 |
| NTLA | INTELLIA THERAPEUTICS INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q1 2018 | Q1 2018 | 1 |
| ARRY | ARRAY BIOPHARMA INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q1 2017 | Q1 2017 | 1 |
| CBMXW | COMBIMATRIX CORPORATION | 1 | 1 | 0.25% | 0.25% | 0.25% | Q3 2017 | Q3 2017 | 1 |
| P103PS | NPS PHARMACEUTICALS | 1 | 1 | 0.24% | 0.24% | 0.24% | Q4 2014 | Q4 2014 | 1 |
| FIXX | HOMOLOGY MEDICINES INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2018 | Q1 2018 | 1 |
| CRDC | CARDICA INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2016 | Q1 2016 | 1 |
| INSM | INSMED INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q2 2017 | Q2 2017 | 1 |
| XNCR | XENCOR | 1 | 1 | 0.24% | 0.24% | 0.24% | Q4 2014 | Q4 2014 | 1 |
| TWTR | TWITTER INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2018 | Q1 2018 | 1 |
| ABCO | ADVISORY BRD CO | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2017 | Q1 2017 | 1 |
| XBIT | XBIOTECH INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q1 2017 | Q1 2017 | 1 |
| TSRO | TESARO INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q1 2018 | Q1 2018 | 1 |
| OXM | OXFORD IMMUNOTEC GLOBA... | 1 | 1 | 0.23% | 0.23% | 0.23% | Q4 2014 | Q4 2014 | 1 |
| EHIC | EHI CAR SVCS LTD | 1 | 1 | 0.23% | 0.23% | 0.23% | Q3 2016 | Q3 2016 | 1 |
| OMER | OMEROS CORP | 1 | 1 | 0.22% | 0.22% | 0.22% | Q2 2017 | Q2 2017 | 1 |
| NEOS | NEOS THERAPEUTICS INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q4 2017 | Q4 2017 | 1 |
| FPRX | FIVE PRIME THERAPEUTIC... | 1 | 1 | 0.22% | 0.22% | 0.22% | Q4 2017 | Q4 2017 | 1 |
| CELLECTAR BIOSCIENCES ... | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2023 | Q3 2023 | 1 | |
| VRAY | VIEWRAY INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q4 2017 | Q4 2017 | 1 |
| SNSS | SUNESIS PHARMACEUTICAL... | 1 | 1 | 0.21% | 0.21% | 0.21% | Q3 2019 | Q3 2019 | 1 |
| FTSV | FORTY SEVEN INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q2 2018 | Q2 2018 | 1 |
| MDCO | MEDICINES CO | 1 | 1 | 0.21% | 0.21% | 0.21% | Q4 2017 | Q4 2017 | 1 |
| CRBP | CORBUS PHARMACEUTICALS... | 1 | 1 | 0.21% | 0.21% | 0.21% | Q3 2016 | Q3 2016 | 1 |
| IMDZ | IMMUNE DESIGN CORP | 1 | 1 | 0.20% | 0.20% | 0.20% | Q4 2017 | Q4 2017 | 1 |
| AC IMMUNE SA | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2022 | Q2 2022 | 1 | |
| PTLA | PORTOLA PHARMACEUTICAL... | 1 | 1 | 0.19% | 0.19% | 0.19% | Q3 2017 | Q3 2017 | 1 |
| P103PS | NPS PHARMACEUTICALS | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2014 | Q4 2014 | 1 |
| FOMX | FOAMIX PHARMACEUTICALS... | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2015 | Q2 2015 | 1 |
| ATHIRA PHARMA INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2022 | Q2 2022 | 1 | |
| ATRA | ATARA BIOTHERAPEUTICS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2017 | Q4 2017 | 1 |
| ACIU | CALL- ACIU 100@7 1/2EX... | 1 | 1 | 0.19% | 0.19% | 0.19% | Q1 2022 | Q1 2022 | 1 |
| AXDX | ACCELERATE DIAGNOSTICS... | 1 | 1 | 0.19% | 0.19% | 0.19% | Q1 2018 | Q1 2018 | 1 |
| ONVO | ORGANOVO HLDGS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q3 2015 | Q3 2015 | 1 |
| NVTA | INVITAE CORP | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2017 | Q1 2017 | 1 |
| AMPE | AMPIO PHARMACEUTICALS INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2018 | Q1 2018 | 1 |
| ESPR | ESPERION THERAPEUTICS ... | 1 | 1 | 0.17% | 0.17% | 0.17% | Q2 2018 | Q2 2018 | 1 |
| STRUCTURE THERAPEUTICS... | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2023 | Q3 2023 | 1 | |
| ARWR | ARROWHEAD RESH CORP | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2015 | Q3 2015 | 1 |
| ACOR | ACORDA THERAPEUTICS INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2017 | Q2 2017 | 1 |
| ANGO | ANGIODYNAMICS | 1 | 1 | 0.15% | 0.15% | 0.15% | Q1 2015 | Q1 2015 | 1 |
| AKUS | AKOUOS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2020 | Q2 2020 | 1 |
| AN2 THERAPEUTICS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2023 | Q3 2023 | 1 | |
| NVTRQ | NUVECTRA CORP | 1 | 1 | 0.14% | 0.14% | 0.14% | Q1 2018 | Q1 2018 | 1 |
| MYGN | MYRIAD GENETICS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2017 | Q2 2017 | 1 |
| AEHR | AEHR TEST SYSTEMS | 1 | 1 | 0.14% | 0.14% | 0.14% | Q1 2017 | Q1 2017 | 1 |
| RIGL | RIGEL PHARMACEUTICALS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2016 | Q3 2016 | 1 |
| STAA | STAAR SURGICAL CO | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2018 | Q2 2018 | 1 |
| ANIP | ANI PHARMACEUTICALS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q1 2018 | Q1 2018 | 1 |
| CYTK | CYTOKINETICS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2017 | Q2 2017 | 1 |
| EYES | SECOND SIGHT MED PRODS... | 1 | 1 | 0.14% | 0.14% | 0.14% | Q1 2016 | Q1 2016 | 1 |
| CDNA | CAREDX INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2016 | Q2 2016 | 1 |
| ABUS | ARBUTUS BIOPHARMA CORP | 1 | 1 | 0.13% | 0.13% | 0.13% | Q1 2020 | Q1 2020 | 1 |
| NVTA | INVITAE CORP | 1 | 1 | 0.13% | 0.13% | 0.13% | Q1 2017 | Q1 2017 | 1 |
| SSH | SUNSHINE HEART INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2015 | Q2 2015 | 1 |
| MNTA | MOMENTA PHARMACEUTICAL... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2017 | Q4 2017 | 1 |
| TWTR | TWITTER INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2018 | Q1 2018 | 1 |
| IMRA | IMARA INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2022 | Q4 2022 | 1 |
| OMER | OMEROS CORP | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2017 | Q1 2017 | 1 |
| CYTR | CYTRX CORP | 1 | 1 | 0.11% | 0.11% | 0.11% | Q2 2016 | Q2 2016 | 1 |
| XFOR | X4 PHARMACEUTICALS INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2019 | Q4 2019 | 1 |
| MARINUS PHARMECEUTICAL... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2023 | Q3 2023 | 1 | |
| PTE | POLARITYTE INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2018 | Q2 2018 | 1 |
| IMGN | IMMUNOGEN INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2017 | Q2 2017 | 1 |
| ONCE | SPARK THERAPEUTICS INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q4 2017 | Q4 2017 | 1 |
| TXMD | THERAPEUTICSMD | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2015 | Q1 2015 | 1 |
| PGNX | PROGENICS PHARMACEUTIC... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2016 | Q3 2016 | 1 |
| AUDC | AUDIOCODES LTD | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2016 | Q2 2016 | 1 |
| RLYP | RELYPSA INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2016 | Q2 2016 | 1 |
| ESPR | ESPERION THERAPEUTIC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q3 2022 | Q3 2022 | 1 |
| ZYNE | ZYNERBA PHARMACEUTICAL... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2018 | Q2 2018 | 1 |
| BCRX | BIOCRYST PHARMACEUTICALS | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2016 | Q3 2016 | 1 |
| NEURODERM LTD | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2017 | Q2 2017 | 1 | |
| PANAWS | PANACEA ACQUISITION CORP | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2020 | Q4 2020 | 1 |
| XBIT | XBIOTECH INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2017 | Q1 2017 | 1 |
| NVIV | INVIVO THERAPEUTICS HL... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2016 | Q1 2016 | 1 |
| CRSP | CRISPR THERAPEUTICS AG | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2018 | Q1 2018 | 1 |
| TEVA | TEVA PHARMACEUTICAL IN... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2018 | Q1 2018 | 1 |
| NVAX | NOVAVAX INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2019 | Q1 2019 | 1 |
| IDYA | IDEAYA BIOSCIENCES INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2022 | Q3 2022 | 1 |
| ENDP | ENDO INTL PLC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2018 | Q1 2018 | 1 |
| GTXI | GTX INC DEL | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2018 | Q3 2018 | 1 |
| CYHHZ | COMMUNITY HEALTH SYS I... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2014 | Q4 2014 | 1 |
| NEOS | NEOS THERAPEUTICS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2017 | Q4 2017 | 1 |
| ZNTL | ZENTALIS PHARMACEUTICA... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2022 | Q3 2022 | 1 |
| NGM | NGM BIOPHARMACEUTICALS... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2022 | Q3 2022 | 1 |
| OCUL | OCULAR THERAPEUTIX INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2022 | Q2 2022 | 1 |
| OHRP | OHR PHARMACEUTICAL INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2015 | Q4 2015 | 1 |
| GLYC | GLYCOMIMETIC INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2023 | Q3 2023 | 1 |
| AXGT | AXOVANT SCIENCES LTD | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2017 | Q3 2017 | 1 |
| RIGL | RIGEL PHARMACEUTICALS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2016 | Q3 2016 | 1 |
| TGTX | TG THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2017 | Q4 2017 | 1 |
| OTLK | OUTLOOK THERAPEUTICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2018 | Q4 2018 | 1 |
| PSTI | PLURISTEM THERAPEUTICS... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2016 | Q4 2016 | 1 |
| OTIC | OTONOMY INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2017 | Q3 2017 | 1 |
| MNTA | MOMENTA PHARMACEUTICAL... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2017 | Q4 2017 | 1 |
| AVEO | AVEO PHARMACEUTICALS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2017 | Q4 2017 | 1 |
| OHRP | OHR PHARMACEUTICAL INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2016 | Q4 2016 | 1 |
Download | |||||||||
The securities at the top of the list , including IOVANCE BIOTHERAPEUTICS INC, IRIDEX CORP, and ARROWHEAD PHARMACEUTICALS INC, are the highest-conviction holdings of ACUTA CAPITAL PARTNERS, LLC.
The conviction is calculated by counting the number of quarters a security has been reported by ACUTA CAPITAL PARTNERS, LLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that ACUTA CAPITAL PARTNERS, LLC owns currently or has owned in the past.